Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research CNS/Neurology Market Research

MR Imaging in Neurosurgery Market - A Global and Regional Analysis: Focus on Types, Products, End User, and Region - Analysis and Forecast, 2022-2031

Best Price Guarantee Length Publisher Published Date SKU
from $5,250 176 Pages BIS Research August, 2022 BIS17383443
Best Price Guarantee
Price from $5,250
Length 176 Pages
Publisher BIS Research
Published Date August, 2022
SKU BIS17383443

MR Imaging in Neurosurgery Market - A Global and Regional Analysis: Focus on Types, Products, End User, and Region - Analysis and Forecast, 2022-2031

Global MR Imaging Market in Neurosurgery Industry Overview

The market size of MR imaging in neurosurgery was valued at $88.7 million in 2021 and is anticipated to reach $150.5 million by the end of 2031, registering a CAGR of 5.52% during the forecast period 2022-2031. The market is driven by factors such as the increasing prevalence of neurological disorders requiring surgical intervention, rising preference for minimally invasive surgeries, growing demand for intraoperative imaging, and technological advancements in the field of robotics and medical imaging.

Market Lifecycle Stage

MR imaging market in neurosurgery is still in the development phase. Increased research and development activities are underway to develop more products.

The opportunity for growth of MR imaging market in neurosurgery lies in the development of cost-effective robotic-assisted MRI systems and the development of MRI-compatible robotic systems.

Impact of COVID-19

The COVID-19 pandemic led to the deferral of MRI performance in the imaging industry. The impact of COVID-19 on imaging facilities is ambiguous, as some imaging techniques such as X-Ray and CT were actively used, whereas MRI and ultrasound were of limited use during the pandemic. Before the COVID-19 pandemic, MR imaging in neurosurgery was majorly undertaken in hospitals and clinical facilities. Owing to factors such as travel restrictions and the risk of transmission of the virus, there was a decrease in MR imaging in neurosurgery.

As the recovery phase of the COVID-19 pandemic begins, MR imaging in neurosurgery procedures is expected to normalize.

Market Segmentation:

Segmentation 1: by Types

  • Conventional MR Imaging Devices
  • Robotic-Assisted MR Imaging Devices
The global MR imaging market in neurosurgery (by type) is expected to be dominated by the conventional MR imaging devices segment.

Segmentation 2: by Products
  • Systems
  • Instruments and Accessories
The global MR imaging market in neurosurgery (by product) in the product segment is expected to be dominated by the systems segment.

Segmentation 3: by End User
  • Hospitals
  • Ambulatory Surgery Centers and Others
The global MR imaging market in neurosurgery (by end user) is dominated by the hospital segment.

Segmentation 4: by Region
  • North America - U.S., Canada
  • Europe - Germany, France, U.K., Italy, Spain, Rest-of-Europe
  • Rest-of-the-World- Japan, China, Rest-of-Rest-of-the-World
Recent Developments in Global MR Imaging Market in Neurosurgery
  • In June 2022, Hyperfine Inc. announced its expansion into Australia and New Zealand with Medical Device Registration and notification.
  • In June 2022, Hyperfine Inc. received FDA Clearance for its two new imaging sequences.
  • In May 2022, Koninklijke Philips N.V. received FDA 510(k) clearance for its latest breakthrough high-performance MR 7700 system.
  • In April 2022, FAULHABER integrated with a new subsidiary, named, PDT Präzisionsdrehteile GmbH from Nürtingen.
  • In March 2022, AiM Medical Robotics raised $3.4 million in seed financing to advance neurosurgery with MRI-compatible robotics.
  • In February 2022, Esaote S.p.A received FDA approval of the Magnifico Open MRI system.
Demand – Drivers and Limitations

Following are the drivers for MR imaging market in neurosurgery:
  • Increasing Prevalence of Neurological Disorders Requiring Surgical Intervention
  • Rising Preference for Minimally Invasive Surgeries
  • Growing Demand for Intraoperative Imaging
  • Technological Advancements in the Field of Robotics and Medical Imaging
The market is expected to face some limitations too due to the following challenges:
  • High Cost of Investment in Robotic-Assisted MRI in Neurosurgeries
  • Limitations of MRI
How Can This Report Add Value to an Organization?

Type: The type segment helps the reader understand the different types of MR imaging in neurosurgery types available in the market. Moreover, the study provides the reader with a detailed understanding of the different products (systems and instruments, and accessories). Furthermore, the study also covers different segments of type (conventional MR imaging devices and robotic-assisted MR imaging devices).

Growth/Marketing Strategy: The global MR imaging market in neurosurgery has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint venture. The favored strategy for the companies has been regulatory and legal activities, partnerships, alliances, and business expansions to strengthen their position in the market. For instance, in June 2022, Hyperfine Inc. received FDA Clearance for its two new imaging sequences, and in November 2021, Medtronic plc partnered with Rune Labs to improve its understanding of neurostimulation with brain data.

Competitive Strategy: Key players in the global MR imaging market in neurosurgery analyzed and profiled in the study involve established and emerging players that offer different products for MR imaging in neurosurgery. Moreover, a detailed competitive benchmarking of the players operating in the global MR imaging market in neurosurgery has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some of the prominent established names in this market are:
  • AiM Medical Robotics
  • Aspect Imaging Ltd.
  • Brainlab AG
  • Canon Inc.
  • Deerfield Management
  • Esaote S.p.A
  • FAULHABER
  • Fonar Corporation
  • Fujifilm Holdings Corporation
  • General Electric Company
  • Hyperfine Inc.
  • Insightec
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Monteris Medical Corporation
  • Profound Medical Corp.
  • Promaxo Inc. (neuro42, Inc.)
  • Siemens AG
  • Synaptive Medical
  • Zimmer Biomet Holdings, Inc.


*PDF email from publisher allows for 1-3 users, with permission to print*


1 Markets
1.1 Global Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion and Exclusion Criteria
1.1.3 Key Findings
1.1.4 Global Market Scenario
1.1.4.1 Realistic Scenario
1.1.4.2 Optimistic Scenario
1.1.4.3 Pessimistic Scenario
1.2 Industry Outlook
1.2.1 Key Trends
1.2.1.1 Development of Portable MRIs
1.2.1.2 High Number of Regulatory Approvals and Partnerships
1.2.1.3 Increasing R&D in the Field of Robotic-Assisted Imaging Systems
1.2.1.4 Development of Patient-Centric MRI Systems (Open MRI and Noiseless Systems)
1.2.1.5 Advancements in Data Acquisition Capabilities of MRI in Neurosurgery
1.2.2 Opportunity Assessment
1.2.3 Patent Analysis
1.2.3.1 Awaited Technological Developments
1.2.3.2 Patent Filing Trend (by Country)
1.2.3.3 Patent Filing Trend (by Year)
1.2.4 Product Benchmarking
1.2.5 Product Pipeline Analysis
1.2.6 MR Imaging Procedure Volume
1.2.7 Case Studies
1.2.7.1 Feasibility and Efficacy of iMRI in Tubular Retractor-Guided Resections of Intrinsic Brain Tumors
1.2.7.2 A New Generation of Commercial Brain Surgery Robot Clinical Application Research
1.3 Impact of COVID-19 on Global MR Imaging in Neurosurgery Market
1.3.1 Impact on MRI Services in the Imaging Industry
1.3.2 Impact on Market Size
1.3.2.1 Pre-COVID-19 Phase
1.3.2.2 During-COVID-19 Phase
1.3.2.3 Post-COVID-19 Phase
1.3.3 Market Entry Barriers and Opportunities
1.4 Business Dynamics
1.4.1 Impact Analysis
1.4.2 Business Drivers
1.4.2.1 Increasing Prevalence of Neurological Disorders Requiring Surgical Intervention
1.4.2.2 Rising Preference for Minimally Invasive Surgeries
1.4.2.3 Growing Demand for Intraoperative Imaging
1.4.2.4 Technological Advancements in the Field of Robotics and Medical Imaging
1.4.3 Business Restraints
1.4.3.1 High Cost of Investment in Robotic-Assisted MRI in Neurosurgeries
1.4.3.2 Limitations of MRI
1.4.4 Business Opportunities
1.4.4.1 Development of Cost-Effective Robotic-Assisted MRI Systems
1.4.4.2 Development of MRI-Compatible Robotic Systems
2 Global MR Imaging in Neurosurgery Market (by Type)
2.1 Opportunity Assessment
2.2 Growth-Share Matrix
2.3 Conventional MR Imaging Devices
2.4 Robotic-Assisted MR Imaging Devices
3 Global MR Imaging in Neurosurgery Market (by Product)
3.1 Opportunity Assessment
3.2 Growth-Share Matrix
3.3 Systems
3.4 Instruments and Accessories
4 Global MR Imaging in Neurosurgery Market (by End User)
4.1 Opportunity Assessment
4.2 Growth-Share Matrix
4.3 Hospitals
4.4 Ambulatory Surgery Centers and Others
5 Region
5.1 North America
5.1.1 Key Findings and Opportunity Assessment
5.1.2 Regulatory Framework
5.1.2.1 U.S.
5.1.2.2 Canada
5.1.3 Market Dynamics
5.1.3.1 Impact Analysis
5.1.4 Sizing and Forecast Analysis
5.1.4.1 North America MR Imaging in Neurosurgery Market (by Type)
5.1.4.1.1 North America Conventional MR Imaging in Neurosurgery Market (by Product)
5.1.4.1.2 North America Robotic-Assisted MR Imaging in Neurosurgery Market (by Product)
5.1.4.2 North America MR Imaging in Neurosurgery Market (by Product)
5.1.4.3 North America MR Imaging in Neurosurgery Market (by End User)
5.1.4.4 North America MR Imaging in Neurosurgery Market (by Country)
5.1.4.4.1 U.S.
5.1.4.4.1.1 Market Dynamics
5.1.4.4.1.2 Market Sizing and Forecast
5.1.4.4.2 Canada
5.1.4.4.2.1 Market Dynamics
5.1.4.4.2.2 Market Sizing and Forecast
5.2 Europe
5.2.1 Key Findings and Opportunity Assessment
5.2.2 Regulatory Framework
5.2.3 Market Dynamics
5.2.3.1 Impact Analysis
5.2.4 Sizing and Forecast Analysis
5.2.4.1 Europe MR Imaging in Neurosurgery Market (by Type)
5.2.4.1.1 Europe Conventional MR Imaging in Neurosurgery Market (by Product)
5.2.4.1.2 Europe Robotic-Assisted MR Imaging in Neurosurgery Market (by Product)
5.2.4.2 Europe MR Imaging in Neurosurgery Market (by Product)
5.2.4.3 Europe MR Imaging in Neurosurgery Market (by End User)
5.2.4.4 Europe MR Imaging in Neurosurgery Market (by Country)
5.2.4.4.1 Germany
5.2.4.4.1.1 Market Dynamics
5.2.4.4.1.2 Market Sizing and Forecast
5.2.4.4.2 France
5.2.4.4.2.1 Market Dynamics
5.2.4.4.2.2 Market Sizing and Forecast
5.2.4.4.3 U.K.
5.2.4.4.3.1 Market Dynamics
5.2.4.4.3.2 Market Sizing and Forecast
5.2.4.4.4 Italy
5.2.4.4.4.1 Market Dynamics
5.2.4.4.4.2 Market Sizing and Forecast
5.2.4.4.5 Spain
5.2.4.4.5.1 Market Dynamics
5.2.4.4.5.2 Market Sizing and Forecast
5.2.4.4.6 Rest-of-Europe
5.2.4.4.6.1 Market Dynamics
5.2.4.4.6.2 Market Sizing and Forecast
5.3 Rest-of-the-World
5.3.1 Key Findings and Opportunity Assessment
5.3.2 Regulatory Framework
5.3.3 Market Dynamics
5.3.3.1 Impact Analysis
5.3.4 Sizing and Forecast Analysis
5.3.4.1 Rest-of-the-World MR Imaging in Neurosurgery Market (by Type)
5.3.4.1.1 Rest-of-the-World Conventional MR Imaging in Neurosurgery Market (by Product)
5.3.4.1.2 Rest-of-the-World Robotic-Assisted MR Imaging in Neurosurgery Market (by Product)
5.3.4.2 Rest-of-the-World MR Imaging in Neurosurgery Market (by Product)
5.3.4.3 Rest-of-the-World MR Imaging in Neurosurgery Market (by End User)
5.3.4.4 Rest-of-the-World MR Imaging in Neurosurgery Market (by Country)
5.3.4.4.1 Japan
5.3.4.4.1.1 Market Dynamics
5.3.4.4.1.2 Market Sizing and Forecast
5.3.4.4.2 China
5.3.4.4.2.1 Market Dynamics
5.3.4.4.2.2 Market Sizing and Forecast
5.3.4.4.3 Rest-of-Rest-of-the-World
5.3.4.4.3.1 Market Dynamics
5.3.4.4.3.2 Market Sizing and Forecast
6 Markets - Competitive Benchmarking & Company Profiles
6.1 Competitive Benchmarking
6.1.1 Key Strategies and Developments
6.1.1.1 Regulatory and Legal Activities
6.1.1.2 Partnerships, Alliances, and Business Expansion
6.1.1.3 New Offerings
6.1.1.4 Funding Activities
6.1.1.5 Mergers and Acquisitions
6.2 Market Share Analysis
6.3 Company Profiles
6.3.1 AiM Medical Robotics
6.3.1.1 Company Overview
6.3.1.2 Role of AiM Medical Robotics in the Global MR Imaging in Neurosurgery Market
6.3.1.3 Recent Developments
6.3.1.4 Analyst Perception
6.3.2 Aspect Imaging Ltd.
6.3.2.1 Company Overview
6.3.2.2 Role of Aspect Imaging Ltd. in the Global MR Imaging in Neurosurgery Market
6.3.2.3 Recent Developments
6.3.2.4 Analyst Perception
6.3.3 Brainlab AG
6.3.3.1 Company Overview
6.3.3.2 Role of Brainlab AG in the Global MR Imaging in Neurosurgery Market
6.3.3.3 Recent Developments
6.3.3.4 Analyst Perception
6.3.4 Canon Inc.
6.3.4.1 Company Overview
6.3.4.2 Role of Canon Inc. in the Global MR Imaging in Neurosurgery Market
6.3.4.3 Financials
6.3.4.4 Recent Developments
6.3.4.5 Analyst Perception
6.3.5 Deerfield Management
6.3.5.1 Company Overview
6.3.5.2 Role of Deerfield Management in the Global MR Imaging in Neurosurgery Market
6.3.5.3 Recent Developments
6.3.5.4 Analyst Perception
6.3.6 Esaote S.p.A
6.3.6.1 Company Overview
6.3.6.2 Role of Esaote S.p.A in the Global MR Imaging in Neurosurgery Market
6.3.6.3 Financials
6.3.6.4 Recent Developments
6.3.6.5 Analyst Perception
6.3.7 FAULHABER
6.3.7.1 Company Overview
6.3.7.2 Role of FAULHABER in the Global MR Imaging in Neurosurgery Market
6.3.7.3 Recent Developments
6.3.7.4 Analyst Perception
6.3.8 Fonar Corporation
6.3.8.1 Company Overview
6.3.8.2 Role of Fonar Corporation in the Global MR Imaging in Neurosurgery Market
6.3.8.3 Financials
6.3.8.4 Recent Developments
6.3.8.5 Analyst Perception
6.3.9 Fujifilm Holdings Corporation
6.3.9.1 Company Overview
6.3.9.2 Role of Fujifilm Holdings Corporation in the Global MR Imaging in Neurosurgery Market
6.3.9.3 Financials
6.3.9.4 Recent Developments
6.3.9.5 Analyst Perception
6.3.10 General Electric Company
6.3.10.1 Company Overview
6.3.10.2 Role of General Electric Company in the Global MR Imaging in Neurosurgery Market
6.3.10.3 Financials
6.3.10.4 Recent Developments
6.3.10.5 Analyst Perception
6.3.11 Hyperfine Inc.
6.3.11.1 Company Overview
6.3.11.2 Role of Hyperfine Inc. in the Global MR Imaging in Neurosurgery Market
6.3.11.3 Financials
6.3.11.4 Recent Developments
6.3.11.5 Analyst Perception
6.3.12 Insightec
6.3.12.1 Company Overview
6.3.12.2 Role of Insightec in the Global MR Imaging in Neurosurgery Market
6.3.12.3 Recent Developments
6.3.12.4 Analyst Perception
6.3.13 Koninklijke Philips N.V.
6.3.13.1 Company Overview
6.3.13.2 Role of Koninklijke Philips N.V. in the Global MR Imaging in Neurosurgery Market
6.3.13.3 Financials
6.3.13.4 Recent Developments
6.3.13.5 Analyst Perception
6.3.14 Medtronic plc
6.3.14.1 Company Overview
6.3.14.2 Role of Medtronic plc in the Global MR Imaging in Neurosurgery Market
6.3.14.3 Financials
6.3.14.4 Recent Developments
6.3.14.5 Analyst Perception
6.3.15 Monteris Medical Corporation
6.3.15.1 Company Overview
6.3.15.2 Role of Monteris Medical Corporation in the Global MR Imaging in Neurosurgery Market
6.3.15.3 Recent Developments
6.3.15.4 Analyst Perception
6.3.16 Profound Medical Corp.
6.3.16.1 Company Overview
6.3.16.2 Role of Profound Medical Corp. in the Global MR Imaging in Neurosurgery Market
6.3.16.3 Financials
6.3.16.4 Recent Developments
6.3.16.5 Analyst Perception
6.3.17 Promaxo Inc. (neuro42, Inc.)
6.3.17.1 Company Overview
6.3.17.2 Role of Promaxo Inc. (neuro42, Inc.) in the Global MR Imaging in Neurosurgery Market
6.3.17.3 Recent Developments
6.3.17.4 Analyst Perception
6.3.18 Siemens AG
6.3.18.1 Company Overview
6.3.18.2 Role of Siemens AG in the Global MR Imaging in Neurosurgery Market
6.3.18.3 Financials
6.3.18.4 Recent Developments
6.3.18.5 Analyst Perception
6.3.19 Synaptive Medical
6.3.19.1 Company Overview
6.3.19.2 Role of Synaptive Medical in the Global MR Imaging in Neurosurgery Market
6.3.19.3 Recent Developments
6.3.19.4 Analyst Perception
6.3.20 Zimmer Biomet Holdings, Inc.
6.3.20.1 Company Overview
6.3.20.2 Role of Zimmer Biomet Holdings, Inc. in the Global MR Imaging in Neurosurgery Market
6.3.20.3 Financials
6.3.20.4 Recent Developments
6.3.20.5 Analyst Perception
List of Figures
Figure 1: Global MR Imaging in Neurosurgery Market Potential, $Million, 2020, 2024, 2027, and 2031
Figure 2: Global MR Imaging in Neurosurgery Market Impact Analysis
Figure 3: MR Imaging in Neurosurgery Market (by Type), $Million, 2021 and 2031
Figure 4: Global MR Imaging in Neurosurgery Market (by Region), $Million, 2021 and 2031
Figure 5: Global MR Imaging in Neurosurgery Market Segmentation
Figure 6: Global MR Imaging in Neurosurgery Market: Research Methodology
Figure 7: Primary Research Sources
Figure 8: Secondary Research
Figure 9: Data Triangulation
Figure 10: Global MR Imaging in Neurosurgery Market, Estimation of Total MRI Procedures
Figure 11: Assumptions and Limitations
Figure 12: Global MR Imaging in Neurosurgery Market, Potential Forecast Scenarios
Figure 13: Global MR Imaging in Neurosurgery Market Size and Growth Potential (Realistic Scenario), $Million, 2018-2031
Figure 14: Global MR Imaging in Neurosurgery Market Size and Growth Potential (Optimistic Scenario), $Million, 2018-2031
Figure 15: Global MR Imaging in Neurosurgery Market Size and Growth Potential (Pessimistic/Conservative Scenario), $Million, 2018-2031
Figure 16: Global MR Imaging in Neurosurgery Market Key Trends, Market Shift, 2022-2031
Figure 17: Global MR Imaging in Neurosurgery Market, Patent Analysis (by Country), January 2018-June 2022
Figure 18: Global MR Imaging in Neurosurgery Market, Patent Analysis (by Year), January 2018-June 2022
Figure 19: Global MR Imaging in Neurosurgery Market, Procedure Volume, Thousands, 2018-2031
Figure 20: Global MR Imaging in Neurosurgery Market, Pre-COVID-19, $Million, 2018-2031
Figure 21: Global MR Imaging in Neurosurgery Market, Procedure Volume, Thousands, 2018-2031
Figure 22: Global MR Imaging in Neurosurgery Market, Impact Analysis
Figure 23: Global MR Imaging in Neurosurgery Market (by Type)
Figure 24: Global MR Imaging in Neurosurgery Market Incremental Opportunity (by Type), $Million, 2021-2031
Figure 25: Global MR Imaging in Neurosurgery Market, Growth-Share Matrix (by Type), 2021-2031
Figure 26: Global Conventional MR Imaging in Neurosurgery Market, $Million, 2018-2031
Figure 27: Global Robotic-Assisted MR Imaging in Neurosurgery Market, $Million, 2018-2031
Figure 28: Global MR Imaging in Neurosurgery Market (by Product)
Figure 29: Global MR Imaging in Neurosurgery Market Incremental Opportunity (by Product), $Million, 2021-2031
Figure 30: Global MR Imaging in Neurosurgery Market, Growth-Share Matrix (by Product), 2021-2031
Figure 31: Global MR Imaging in Neurosurgery Market (by Systems), $Million, 2018-2031
Figure 32: Global MR Imaging in Neurosurgery Market, Systems (by Type), $Million, 2018-2031
Figure 33: Global MR Imaging in Neurosurgery Market (by Instruments and Accessories), $Million, 2018-2031
Figure 34: Global MR Imaging in Neurosurgery Market, Instruments and Accessories (by Type), $Million, 2018-2031
Figure 35: Global MR Imaging in Neurosurgery Market (by End User)
Figure 36: Global MR Imaging in Neurosurgery Market Incremental Opportunity (by End User), $Million, 2021-2031
Figure 37: Global MR Imaging in Neurosurgery Market, Growth-Share Matrix (by End User), 2021-2031
Figure 38: Global MR Imaging in Neurosurgery Market (Hospitals), $Million, 2018-2031
Figure 39: Global MR Imaging in Neurosurgery Market (Ambulatory Surgery Centers and Other Settings), $Million, 2018-2031
Figure 40: Global MR Imaging in Neurosurgery Market Size (by Region), 2021
Figure 41: North America MR Imaging in Neurosurgery Market Incremental Opportunity (by Country), $Million, 2021-2031
Figure 42: North America MR Imaging in Neurosurgery Market, $Million, 2018-2031
Figure 43: North America MR Imaging in Neurosurgery Market (by Type), $Million, 2018-2031
Figure 44: North America Conventional MR Imaging in Neurosurgery Market (by Product), $Million, 2018-2031
Figure 45: North America Robotic-Assisted MR Imaging in Neurosurgery Market (by Product), $Million, 2018-2031
Figure 46: North America MR Imaging in Neurosurgery Market (by Product), $Million, 2018-2031
Figure 47: North America MR Imaging in Neurosurgery Market (by End User), $Million, 2018-2031
Figure 48: U.S. MR Imaging in Neurosurgery Market, $Million, 2018-2031
Figure 49: Canada MR Imaging in Neurosurgery Market, $Million, 2018-2031
Figure 50: Europe MR Imaging in Neurosurgery Market Incremental Opportunity (by Country), $Million, 2021-2031
Figure 51: Europe MR Imaging in Neurosurgery Market, $Million, 2018-2031
Figure 52: Europe MR Imaging in Neurosurgery Market (by Type), $Million, 2018-2031
Figure 53: Europe Conventional MR Imaging in Neurosurgery Market (by Product), $Million, 2018-2031
Figure 54: Europe Robotic-Assisted MR Imaging in Neurosurgery Market (by Product), $Million, 2018-2031
Figure 55: Europe MR Imaging in Neurosurgery Market (by Product) $Million, 2018-2031
Figure 56: Europe MR Imaging in Neurosurgery Market (by End User), $Million, 2018-2031
Figure 57: Germany MR Imaging in Neurosurgery Market, $Million, 2018-2031
Figure 58: France MR Imaging in Neurosurgery Market, $Million, 2018-2031
Figure 59: U.K. MR Imaging in Neurosurgery Market, $Million, 2018-2031
Figure 60: Italy MR Imaging in Neurosurgery Market, $Million, 2018-2031
Figure 61: Spain MR Imaging in Neurosurgery Market, $Million, 2018-2031
Figure 62: Rest-of-Europe MR Imaging in Neurosurgery Market, $Million, 2018-2031
Figure 63: Rest-of-the-World MR Imaging in Neurosurgery Market Incremental Opportunity (by Country), $Million, 2021-2031
Figure 64: Rest-of-the-World MR Imaging in Neurosurgery Market, $Million, 2018-2031
Figure 65: Rest-of-the-World MR Imaging in Neurosurgery Market (by Type), $Million, 2018-2031
Figure 66: Rest-of-the-World Conventional MR Imaging in Neurosurgery Market (by Product), $Million, 2018-2031
Figure 67: Rest-of-the-World Robotic-Assisted MR Imaging in Neurosurgery Market (by Product), $Million, 2018-2031
Figure 68: Rest-of-the-World MR Imaging in Neurosurgery Market (by Product) $Million, 2018-2031
Figure 69: Rest-of-the-World MR Imaging in Neurosurgery Market (by End User), $Million, 2018-2031
Figure 70: Japan MR Imaging in Neurosurgery Market, $Million, 2018-2031
Figure 71: China MR Imaging in Neurosurgery Market, $Million, 2018-2031
Figure 72: Rest-of-Rest-of-the-World MR Imaging in Neurosurgery Market, $Million, 2018-2031
Figure 73: Total Number of Key Developments in MR Imaging in Neurosurgery Market, 2018-2022
Figure 74: Regulatory and Legal Activities, January 2018-May 2022
Figure 75: Partnerships, Alliances, and Business Expansion Activities, January 2018-May 2022
Figure 76: New Offerings, January 2018-May 2022
Figure 77: Funding Activities, January 2018-May 2022
Figure 78: Mergers and Acquisitions, January 2018-May2022
Figure 79: Market Share Analysis (by Company) for the Global MR Imaging in Neurosurgery Market, $Million, 2021
Figure 80: AiM Medical Robotics: Product Portfolio
Figure 81: Aspect Imaging Ltd: Product Portfolio
Figure 82: Brainlab AG: Product Portfolio
Figure 83: Canon Inc.: Product Portfolio
Figure 84: Canon Inc.: Overall Financials, $Million, 2019-2021
Figure 85: Canon Inc.: Segment Revenues, $Million, 2019-2021
Figure 86: Canon Inc.: Net Revenue (by Region), $Million, 2019-2021
Figure 87: Canon Inc.: R&D Expenditure, $Million, 2019-2021
Figure 88: Deerfield Management: Product Portfolio
Figure 89: Esaote S.p.A.: Product Portfolio
Figure 90: Esaote S.p.A.: Overall Financials, $Million, 2020-2021
Figure 91: Esaote S.p.A.: R&D Expenditure, $Million, 2020-2021
Figure 92: FAULHABER: Product Portfolio
Figure 93: Fonar Corporation: Product Portfolio
Figure 94: Fonar Corporation: Overall Financials, $Million, 2019-2021
Figure 95: Fonar Corporation: R&D Expenditure, $Million, 2019-2021
Figure 96: Fujifilm Holdings Corporation: Product Portfolio
Figure 97: Fujifilm Holdings Corporation: Overall Financials, $Million, 2020-2022
Figure 98: Fujifilm Holdings Corporation: Net Revenue (by Business Segment), $Million, 2021-2022
Figure 99: Fujifilm Holdings Corporation: R&D Expenditure, $Million, 2020-2022
Figure 100: General Electric Company: Product Portfolio
Figure 101: General Electric Company: Overall Financials, $Million, 2019-2021
Figure 102: General Electric Company: Segment Revenues, $Million, 2019-2021
Figure 103: General Electric Company: Net Revenue (by Region), $Million, 2019-2021
Figure 104: General Electric Company: R&D Expenditure, $Million, 2019-2021
Figure 105: Hyperfine Inc.: Product Portfolio
Figure 106: Hyperfine Inc.: Overall Financials, $Million, 2020-2021
Figure 107: Hyperfine Inc.: R&D Expenditure, $Million, 2020-2021
Figure 108: Insightec: Product Portfolio
Figure 109: Koninklijke Philips N.V.: Product Portfolio
Figure 110: Koninklijke Philips N.V.: Overall Financials, $Million, 2019-2021
Figure 111: Koninklijke Philips N.V.: Segment Revenues, $Million, 2019-2021
Figure 112: Koninklijke Philips N.V.: Net Revenue (by Region), $Million, 2019-2021
Figure 113: Koninklijke Philips N.V.: R&D Expenditure, $Million, 2019-2021
Figure 114: Medtronic plc: Product Portfolio
Figure 115: Medtronic plc: Overall Financials, $Million, 2019-2021
Figure 116: Medtronic plc: Segment Revenues, $Million, 2019-2021
Figure 117: Medtronic plc: Net Revenue (by Region), $Million, 2019-2021
Figure 118: Medtronic plc: R&D Expenditure, $Million, 2019-2021
Figure 119: Monteris Medical Corporation: Product Portfolio
Figure 120: Profound Medical Corp.: Product Portfolio
Figure 121: Profound Medical Corp.: Overall Financials, $Million, 2019-2021
Figure 122: Profound Medical Corp.: R&D Expenditure, $Million, 2019-2021
Figure 123: Promaxo Inc. (Neuro42 Inc.): Product Portfolio
Figure 124: Siemens AG: Product Portfolio
Figure 125: Siemens AG: Overall Financials, $Million, 2020-2021
Figure 126: Siemens AG: R&D Expenditure, $Million, 2019-2021
Figure 127: Siemens Healthineers, Revenue Share
Figure 128: Imaging Segment, Revenue Share
Figure 129: Synaptive Medical: Product Portfolio
Figure 130: Zimmer Biomet Holdings, Inc.: Overall Product Portfolio
Figure 131: Zimmer Biomet Holdings, Inc.: Overall Financials, $Million, 2019-2021
Figure 132: Zimmer Biomet Holdings, Inc.: Net Revenue (by Business Segment), $Million, 2019-2021
Figure 133: Zimmer Biomet Holdings, Inc.: Net Revenue (by Region), $Million, 2019-2021
Figure 134: Zimmer Biomet Holdings, Inc.: R&D Expenditure, $Million, 2019-2021
List of Tables
Table 1: Global MR Imaging in Neurosurgery Market, Quarterly Key Developments Analysis, January 2018-June 2022
Table 2: Key Questions Answered in the Report
Table 3: Global MR Imaging in Neurosurgery Market, Product Benchmarking
Table 4: Pipeline Products of MR Imaging in Neurosurgery Market
Table 5: Global MR Imaging in Neurosurgery Market, Key Entry Barriers and Possible Solutions
Table 6: FDA Recognized MRI Scanners Voluntary Consensus Standards
Table 7: North America MR Imaging in Neurosurgery Market, Dynamics Impact Analysis
Table 8: Europe MR Imaging in Neurosurgery Market Dynamics Impact Analysis
Table 9: Rest-of-the-World MR Imaging in Neurosurgery Market Regulations
Table 10: Rest-of-the-World MR Imaging in Neurosurgery Market Dynamics Impact Analysis

$5,250
$8,100

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings